Treats nosocomial pneumonia due to methicillin-susceptible Staphylococcus aureus…. ANDA 76890, held by Chartwell Molecular. Levofloxacin.
As of Nov 16, 2026, ANDA 76890 (Levofloxacin), held by Chartwell Molecular, was first approved by FDA on Mar 30, 2012, with 11 approved supplements and 0 published complete response letters.
Levofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4 ). Pneumonia: Nosocomial and Community Acquired ( 1.2, 1.3 ) Skin and Skin Structure Infections (SSSI): Complicated and Uncomplicated Chronic bacterial prostatitis Inhalational Anthrax, Post-Exposure in adult and pediatric patients Plague in adult and pediatric patients Urinary Tract Infections (UTI): Complicated ( 1.9, 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 30, 2012 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Rx |
| Sep 20, 2024 | Supplement 19Labeling · Standard review | Approved | None posted |
| Aug 22, 2022 | Supplement 18Labeling · Standard review | Approved | None posted |
| Apr 6, 2020 | Supplement 16Labeling · Standard review | Approved | None posted |
| Apr 6, 2020 | Supplement 17Labeling · Standard review | Approved | None posted |
| May 7, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 9Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 8Labeling · Standard review | Approved | None posted |
| Dec 3, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 3, 2014 | Supplement 4Labeling · Standard review | Approved | None posted |
| Mar 30, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters